What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

AGE Reader mu receives market approval in South Korea

Groningen, the Netherlands – February 27, 2018.

The AGE Reader mu has received medical device approval from the Korean Ministry of Food and Drug Safety (MFDS). This allows the Korean AGE Reader distributor, DiosPharma, to market the AGE Reader mu as a medical device.

Korean healthcare professionals are now allowed to use the AGE Reader mu in clinical practice. Immediately upon receiving the official regulatory approval DiosPharma successfully started the market introduction. Tim Souk, CEO of DiosPharma: “Recently, the Korean market is interested in AGE parameter from the media and the doctors. I am very excited and pleased to have registered the AGE Reader mu device at the right time. We have successfully held the first seminar in September in 2017 with the goal of selling more than 300 units in 2018.”

After receiving regulatory approval in China and Japan earlier, this approval in Korea is another milestone in the business development in Asia for Diagnoptics. Bart van den Berg, CEO of Diagnoptics, is confident that DiosPharma will be successful in marketing the AGE Reader: “Already from the first contact DiosPharma showed to be a professional and dedicated partner. By creating awareness about AGEs and obtaining this regulatory approval DiosPharma created a strong basis to build a promising business. This has immediately been confirmed by a first substantial order and more expected to come”.

Share this link on:

Latest news items

  1. AGE Reader mu receives market approval in South Korea 27 February 2018
  2. Diagnoptics appoints SMT Medical as new distributor in Germany 15 January 2018
  3. Breakthrough publication: diabetes screening with AGE Reader 24 November 2017
  4. AGE Reader product updates at EASD 2017 – Lisbon 13 September 2017
  5. MSP bodmann GmbH appointed as new distributor in Germany 29 June 2017
  6. New key publication: large scale study in metabolic syndrome 13 June 2017
  7. Diagnoptics appoints DiosPharma as the new Korean distributor 7 November 2016
  8. Visit Diagnoptics at the EASD congress 2016 in Munich 26 August 2016
  9. Selista appointed as new Japanese distributor for the AGE Reader mu 19 May 2016
  10. Diagnoptics bei dem DDG Kongress in Berlin 16 April 2016
  11. Diagnoptics receives Chinese market approval for AGE Reader SU 12 February 2016
  12. New patent granted to Diagnoptics in Japan and EU. 7 January 2016
  13. Diagnoptics receives Japanese market approval for AGE Reader mu. 11 September 2015
  14. Diagnoptics nominated for Deloitte Technology Fast50 7 September 2015
  15. Scientific review emphasises need for AGE measurements and interventions 16 July 2015
  16. Dutch government supports Diagnoptics and CTMM research project 6 July 2015
  17. Key publication: AGE Reader predicts amputation 5 May 2015
  18. New AGE Reader video available: quick start guide and user instructions. 3 April 2015
  19. Diagnoptics appoints Forel Medical as new Polish distributor 3 March 2015
  20. Diagnoptics appoints Microcaya as new Spanish distributor 6 February 2015
  21. Diagnoptics appoints ANL Produkter AB as new Swedish distributor 8 December 2014
  22. Exciting video: AGE Reader clinical case study 19 September 2014
  23. Review about AGE Reader in assessing CV risk and risk of diabetes 5 September 2014
  24. Excellent presentation about Advanced Glycation Endproducts (Dutch) 1 August 2014
  25. Editorial confirms added value of AGE Reader in atherosclerosis 25 March 2014
  26. Breakthrough publication: AGE Reader in atherosclerosis 11 March 2014
  27. German review AGE Reader 27 January 2014
  28. Upcoming Conferences 20 January 2014
  29. DiagnOptics moved to another location. 1 January 2014
  30. AGE Reader on national television 14 October 2013
  31. A.J. Smit appointed professor at the UMCG 23 September 2013
  32. Visit DiagnOptics at the EASD 2013 15 August 2013
  33. Clinical validation Diab-spot published 12 July 2013
  34. DiagnOptics receives CE mark approval for AGE Reader mu 17 May 2013
  35. DiagnOptics to show new product at international diabetes meetings in 2013 7 December 2012
  36. AGE Reader presented at German national diabetes conference in Berlin. 23 November 2012
  37. Successful introduction of the AGE Reader mu 22 October 2012
  38. Important role of AGE Reader shown in recent international publications 30 July 2012
  39. DiagnOptics present at the EASD 2012 in Berlin 20 July 2012
  40. DiagnOptics receives Health Canada approval for Diab-spot 1 May 2012
  41. DiagnOptics and PATH partner on project on diabetes screening in India 6 February 2012
  42. New product for diabetes detection, Diab-spot, introduced in Madrid. 19 April 2011
  43. DiagnOptics receives Health Canada approval for the AGE Reader. 15 March 2011
  44. DiagnOptics receives ISO 13485 certification. 1 June 2010
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.